News about Clinical Trials

MMS Holdings, Friends of Cancer Research Partner to Develop Decision Frameworks for Interim Survival Data in Oncology Trials

MMS Holdings (MMS) has been selected by Friends of Cancer Research (Friends) to support the development of practical decision frameworks to inform the interpretation of interim overall survival (OS) data in oncology clinical trials.

Clinical Trials | 20/08/2025 | By Dineshwori |  197

Galvanize Therapeutics Begins Clinical Study of Aliya Pulsed Electric Field Ablation

Galvanize Therapeutics has announced the enrollment of the first patient in the PROPEL Registry, a multicenter observational study designed to evaluate the clinical application, safety, and outcomes of the Aliya Pulsed Electric Field (PEF) ablation system for soft tissue lesions.

Clinical Trials | 18/08/2025 | By Dineshwori |  237

Basilea Secures Global Rights to Venatorx's Phase 3-Ready Oral Antibiotic Combination for Complicated UTIs

The oral beta-lactam/beta-lactamase inhibitor (BL/BLI) combination is phase 3-ready and being developed as a potential treatment for complicated urinary tract infections (cUTI), including pyelonephritis.

Clinical Trials | 16/08/2025 | By Darshana |  202

Novartis Advances Ianalumab Toward Approval for Sjogren's Disease After Phase III Success

Novartis has reported positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with active Sjogren's disease.

Clinical Trials | 11/08/2025 | By Dineshwori |  192

Sun Pharma's Phase 3 Clinical Trials of ILUMYA in Active Psoriatic Arthritis Achieve Primary Endpoint

Sun Pharmaceutical Industries has reported positive top-line results from two Phase 3 trials (INSPIRE-1 and INSPIRE-2), demonstrating that ILUMYA (tildrakizumab 100 mg) significantly improved symptoms of active psoriatic arthritis over 24 weeks compared to placebo.

Clinical Trials | 21/07/2025 | By Mrinmoy Dey |  300

CDSCO Mandates Online Submission of CGTP Clinical Trial Applications via SUGAM Portal

For now on, offline submissions of clinical trial applications for Cell and Gene Therapy Products (CGTPs) will not be accepted by the CDSCO.

Clinical Trials | 11/07/2025 | By Dineshwori |  343

Klotho Neurosciences Advances Gene Therapy Manufacturing for ALS Treatment

Klotho Neurosciences has announced the initiation of manufacturing and process development for KLTO-202, its investigational gene therapy targeting ALS, with plans to begin clinical trials by Q3 next year.

Clinical Trials | 02/07/2025 | By Mrinmoy Dey |  276

Experts to discuss MedDRA's crucial role in global medical research through standardizing clinical trials

Scheduled for June 20, 2025, from 4:00 PM to 5:00 PM IST, this virtual session aims to demystify MedDRA (Medical Dictionary for Regulatory Activities), a globally recognized terminology used to harmonize medical information in regulatory communication and clinical research.<br />

Clinical Trials | 18/06/2025 | By Darshana |  139

Orbis India sees need to handle preventive ophthalmic issues by incorporating eye screenings into primary healthcare

Orbis India sees the need to advance preventive ophthalmic issues by incorporating eye screenings into primary healthcare. This is because primary care is the first point of contact in the healthcare system for most people, making it an ideal setting for preventive interventions.

Clinical Trials | 16/06/2025 | By Darshana |  202

Novavax's Covid-19-influenza combination and stand-alone influenza vaccine candidates showed robust immune responses and were well tolerated in initial coh

Novavax, Inc. announced results of the initial cohort of its Covid-19-Influenza Combination (CIC) and stand-alone trivalent hemagglutinin nanoparticle seasonal influenza (tNIV) phase 3 trial that showed both the CIC and flu vaccine candidates induced immune responses similar to licensed comparators Nuvaxovid and Fluzone HD, respectively.

Clinical Trials | 13/06/2025 | By Darshana |  130